Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort

Boehringer Ingelheim

Overview

The SCOLTA project is a system for online surveying of adverse events to recently commercialized antiretroviral drugs and a sentinel for unexpected and late adverse events reactions arising during any antiretroviral treatment.Aim of the proposed study is: 1. to evaluate the prevalence and incidence of serious adverse events and serious unexpected adverse events in HIV-infected patients enrolled in the SCOLTA project Tipranavir cohort and to identify possible risk factors 2. the evaluation of tipranavir containing regimens durability, considering treatment interruption for each reason.

Study Type

OBSERVATIONAL

Conditions

HIV Infections

Interventions

TipranavirDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients \> 18 years old HIV infected treated with tipranavir Exclusion Criteria:

Outcomes

Primary Outcomes

To evaluate the prevalence and incidence of serious adverse events and serious unexpected adverse events in HIV infected patients enrolled in Tipranavir cohort and to identify possible risk factors

Time frame: 48wks

Secondary Outcomes

the evaluation of tipranavir containing regimens durability, considering treatment interruption for each reason

Time frame: 48wks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.